Platform
Company
Coagulation
Review status
Currently under review
Pending specialist review and validation.
This test measures the activity of Factor X, a vitamin K dependent protein made by your liver that helps your blood form stable clots. It is a functional assay, which means it evaluates how well Factor X works in the clotting process rather than how much of the protein is present.
The term 1:5 refers to a standardized dilution used during the laboratory procedure. Using a set dilution helps the lab obtain accurate, reliable results across a wide range of patient samples and reduces the effect of substances that can interfere with clotting tests.
Doctors use this test to investigate unusual bleeding, easy bruising, or abnormal screening clotting tests. It helps distinguish between an inherited Factor X deficiency and conditions that lower Factor X activity later in life, such as liver disease, low vitamin K, certain autoimmune problems, or protein loss into the kidneys or gut. It can also be helpful when planning procedures if there is concern about bleeding risk.
Some medicines affect Factor X activity or the way this test reads, so your care team may use it alongside other tests to get a complete picture. Results are interpreted together with your symptoms, exam findings, and other laboratory studies to understand the cause and guide treatment.
If activity is lower than expected, it can point to a deficiency of Factor X or the presence of an inhibitor that interferes with clotting. Your clinician may order follow-up testing, such as a mixing study or repeat measurement after addressing possible causes, and will review your medications, nutrition, and liver health.
Higher-than-expected activity is uncommon and usually not concerning by itself. Unexpected results are often repeated to confirm and to rule out sample collection or handling issues. Do not change or stop any medication unless your clinician instructs you to do so.
Depending on the suspected cause, next steps might include treating an underlying condition, adjusting medicines, ensuring adequate vitamin K intake, or referral to a hematology specialist. If an inherited disorder is suspected, genetic testing and family screening may be discussed.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Direct oral anticoagulants, warfarin, and heparin can lower measured Factor X activity or interfere with clot-based assays. Always tell the lab and your clinician about all prescription and over-the-counter medicines and supplements.
Clotting tests require a properly filled blue-top citrate tube, timely processing, and avoidance of clots or hemolysis. Underfilling, delays to the lab, or a traumatic draw can artifactually change the result.
Factor X is made in the liver and requires vitamin K. Liver disease, poor intake, malabsorption, or prolonged broad-spectrum antibiotics can reduce activity.
Lupus anticoagulant and rare specific inhibitors can affect clot-based assays and make activity appear lower. Mixing studies and alternative methods help clarify true deficiency versus inhibition.
Transfusion of plasma or use of prothrombin complex concentrates and other factor products can temporarily raise activity and mask an underlying deficiency.
Acute illness, inflammation, pregnancy, and severe amyloidosis can alter Factor X levels or assay behavior. Your clinician will interpret results in the context of your overall health.
References